NCT00752362View on ClinicalTrials.gov

Per-cutaneous Intervention Based Paclitaxel and Sirolimus-Eluting Versus Bare Stents for the Treatment of de Novo Coronary Lesions (PAINT)

PHASE4CompletedINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

May 31, 2008

Conditions
Coronary Restenosis
Interventions
DEVICE

Milennium Matrix® (Control)

Percutaneous coronary intervention with bare metal stent

DEVICE

Infinnium®

Percutaneous coronary intervention with paclitaxel-eluting stent

DEVICE

Supralimus®

Percutaneous coronary intervention with sirolimus-eluting stent

Trial Locations (11)

60430-370

Hospital Universitário Walter Cantídio, Fortaleza

29042-755

Hospital Universitário Cassiano Antonio de Moraes, Vitória

29156-580

Hospital Meridional Intercath, Vitória

34000-000

Hospital Biocor, Belo Horizonte

20941-150

Rede D'Or de Hospitais, Rio de Janeiro

59054-630

Hospital Natal Center, Natal

90610-000

Hospital São Lucas da PUCRS, Porto Alegre

04024-002

Hospital São Paulo - UNIFESP, São Paulo

05022-001

Hospital São Camilo, São Paulo

08270-070

Hospital Santa Marcelina, São Paulo

05403-900

Instituto do Coração - InCor, São Paulo

Sponsors

Collaborators (1)

CMS Medical
All Listed Sponsors
collaborator

CMS Medical

INDUSTRY

lead

Sahajanand Medical Technologies Limited

INDUSTRY

NCT00752362 - Per-cutaneous Intervention Based Paclitaxel and Sirolimus-Eluting Versus Bare Stents for the Treatment of de Novo Coronary Lesions (PAINT) | Biotech Hunter | Biotech Hunter